Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma. Nat Med. 2023;29(9):2295–306. https://doi.org/10.1038/s41591-023-02491-5. Article PubMed PubMed Central CAS Google Scholar Zhao B, Li H, Xia Y, et al. Immune checkpoint of B7–H3 in...
Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma Blood Adv, 5 (8) (2021), pp. 2196-2215 View PDFView articleCrossrefView in ScopusGoogle Scholar 51 J Sam, S Colombetti, T Fauti, et al. Combination of T-cell bispecif...